Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Molecular Partners Ag (MOLN) Invested Capital (2021 - 2025)

Historic Invested Capital for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to $119418.4.

  • Molecular Partners Ag's Invested Capital fell 2544.67% to $119418.4 in Q3 2025 from the same period last year, while for Sep 2025 it was $119418.4, marking a year-over-year decrease of 2544.67%. This contributed to the annual value of $160997.9 for FY2024, which is 1905.51% down from last year.
  • Molecular Partners Ag's Invested Capital amounted to $119418.4 in Q3 2025, which was down 2544.67% from $128836.0 recorded in Q2 2025.
  • In the past 5 years, Molecular Partners Ag's Invested Capital registered a high of $276.1 million during Q2 2022, and its lowest value of $116355.1 during Q4 2021.
  • Moreover, its 5-year median value for Invested Capital was $210518.3 (2023), whereas its average is $42.5 million.
  • As far as peak fluctuations go, Molecular Partners Ag's Invested Capital skyrocketed by 10979.51% in 2022, and later crashed by 9992.51% in 2025.
  • Molecular Partners Ag's Invested Capital (Quarter) stood at $116355.1 in 2021, then skyrocketed by 109.8% to $244107.4 in 2022, then dropped by 18.52% to $198898.0 in 2023, then decreased by 18.71% to $161680.6 in 2024, then dropped by 26.14% to $119418.4 in 2025.
  • Its Invested Capital was $119418.4 in Q3 2025, compared to $128836.0 in Q2 2025 and $142582.7 in Q1 2025.